Experience

Davis Polk advised the initial purchasers in connection with BRF’s $750 million offering of 4.875% senior notes due 2030, which were issued pursuant to Rule 144A and Regulation S under the…

Davis Polk advised the placement facilitation agents in connection with the placement outside of Mexico of Ps. 1 billion aggregate principal amount of the 7.930% Certificados Bursátiles due…

Davis Polk advised the dealer manager in connection with JBS Investments GmbH’s (1) cash tender offer and consent solicitation for any and all of the outstanding $750 million…

Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering by JBS USA Lux S.A., JBS USA Food Company and JBS USA Finance, Inc. of $1.25 billion…

Davis Polk advised Cosan Limited in connection with its $750 million offering of 5.500% notes due 2029, which were issued pursuant to Rule 144A and Regulation S under the Securities Act,…

Davis Polk advised Afya Limited on its $300.3 million initial public offering of 15,805,841 Class A common shares, which includes the full exercise of the underwriters’ option to…

Davis Polk advised the respective agents of the Brazilian underwriters in connection with Neoenergia S.A.’s initial public offering of 239,251,040 common shares for an aggregate amount…

Davis Polk advised Notre Dame Intermédica Participações S.A. in connection with the equity offering by Bain Capital, the controlling shareholder of Notre Dame Intermédica, of 60,000,000…

Davis Polk advised the initial purchasers in connection with a $500 million offering of 5.250% notes due 2029 by Ultrapar International S.A., which were issued pursuant to Rule 144A and…

Davis Polk is advising Natura Cosméticos S.A. on its all-share acquisition of Avon Products, Inc. The transaction, which is expected to close in early 2020, is subject to customary closing…